Skip to content

13F-HR filed by CHARLES SCHWAB INVESTMENT MANAGEMENT INC

CHARLES SCHWAB INVESTMENT MANAGEMENT INC filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-14, with 3,508 holding rows worth $279,236,282,000.

Accession
0001085146-22-004055
Filed
2022-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2022

A combination report, 3,562 entries on the cover page, a total value of $279,236,282,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $279,236,282,000 with VALUE read as thousands by filing date, 13F file number 028-03128. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SURFACE ONCOLOGY INC86877M209COM12,172$13,000thousands by filing date
HALLMARK FINL SERVICES INC40624Q203COM12,358$13,000thousands by filing date
BIOTRICITY INC COM NEW09074H104Stock16,000$13,000thousands by filing date
SAB BIOTHERAPEUTICS INC78397T103COM16,238$12,000thousands by filing date
Ohr Pharmaceutical Inc64132K102COM29,716$12,000thousands by filing date
ADAMIS PHARMACEUTICALS CORP00547W208COM NEW56,257$12,000thousands by filing date
GREENBOX POS39366L208COM NEW10,419$11,000thousands by filing date
MEDAVAIL HOLDINGS INC58406B103COM11,882$10,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001085146-22-004055this filing2022-11-14acceptance time not in the bulk data set
13F-HR/A 0001085146-24-000007 added2024-01-04acceptance time not in the bulk data set